$BLTE
Belite Bio, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
BLTE chart
What traders are saying about $BLTE
Latest postsBelite Bio, Inc news
- What's Driving the Geographic Atrophy Market Boom? Experts
openPR.com ·
- Age-Related Macular Degeneration Pipeline 2026: Therapeutic Candidates, Clinical Trial Insights, and Companies Leading Drug Development | Astellas Pharma, Iveric Bio, Apellis Pharma, Novartis, Alkeus
StreetInsider ·
- Belite Bio, Inc Estimates – NASDAQ:BLTE
TradingView ·
- Do Multiple Drug Filings Change The Bull Case For Belite Bio (BLTE)?
Simply Wall Street ·
- BLTE Options Chain — NASDAQ:BLTE
TradingView ·
- Why (BLTE) Price Action Is Critical for Tactical Trading
Stock Traders Daily ·
- Belite Bio Announces Uplisting to the Nasdaq Global Select Market
Yahoo Finance ·
- Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets
Yahoo Finance ·
- Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
Yahoo Finance ·
- Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
Yahoo Finance ·
- Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
Yahoo Finance ·
- Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
Yahoo Finance ·
Belite Bio, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$77.6M | -$36.1M | -$31.6M | -$12.6M |
| Diluted EPS | $-2.31 | $-1.18 | $-1.19 | $-0.63 |
| Total assets (year end) | $780.6M | $152.1M | $94.6M | $44.3M |
| Cash and equivalents (year end) | $352.9M | $31.7M | $88.2M | $42.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Belite Bio, Inc
- Ticker
- BLTE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1889109
- Former names
- BELITE BIO, INC
Frequently asked questions
What exchange is Belite Bio, Inc listed on?
Belite Bio, Inc trades on the Nasdaq under the ticker symbol BLTE.
What industry is Belite Bio, Inc in?
Belite Bio, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Belite Bio, Inc headquartered?
Belite Bio, Inc's business address on file with the SEC is in San Diego, CA.
When does Belite Bio, Inc's fiscal year end?
Belite Bio, Inc's fiscal year ends on December 31.